Protective Effects of Royal Jelly on Oxymetholone-Induced Liver Injury in Mice

Vahid Nejati1, Ensieh Zahmatkesh1, Mohammad Babaei2

  • 1Department of Histology and Embryology, Faculty of Science, Urmia University, Urmia, Iran.

Abstract

Insights

Royal jelly (RJ) offers partial protection against oxymetholone (OXM)-induced liver damage in mice. RJ supplementation improved antioxidant capacity and liver enzyme levels, mitigating OXM toxicity.

Area of Science:

  • Hepatology
  • Toxicology
  • Natural Product Research

Background:

  • Oxidative liver injury is a significant concern.
  • Oxymetholone (OXM) is known to induce liver toxicity.
  • Investigating natural compounds for hepatoprotective effects is crucial.

Purpose of the Study:

  • To evaluate the protective potential of royal jelly (RJ) against oxymetholone (OXM)-induced oxidative liver injury.
  • To assess the impact of RJ on key biomarkers of liver damage and oxidative stress.
  • To determine the efficacy of RJ in mitigating OXM-induced hepatotoxicity in a murine model.

Main Methods:

  • Adult male NMRI mice were divided into four groups.
  • Groups received either oxymetholone (OXM) or royal jelly (RJ) at specific dosages for 30 days.
  • Control groups received saline or RJ only.

Main Results:

  • Oxymetholone administration significantly decreased total antioxidant capacity and catalase activity, while increasing malondialdehyde levels.
  • Mice treated with OXM exhibited elevated liver enzymes (ALT, AST, ALP) and histopathological liver damage.
  • Royal jelly (100 mg/kg) significantly ameliorated these OXM-induced changes, improving antioxidant status and liver enzyme profiles.

Conclusions:

  • Royal jelly demonstrates a partial protective effect against oxymetholone-induced liver toxicity in mice.
  • RJ supplementation may help mitigate oxidative stress and liver damage caused by OXM.
  • Further research into RJ's hepatoprotective mechanisms is warranted.

Related Concept Videos